Loading...
•
Dec 31, 2019
Integra LifeSciences Q4 2019 Earnings Report
Reported an increase in revenue and adjusted earnings per diluted share compared to Q4 2018.
Key Takeaways
Integra LifeSciences reported a 3.1% increase in revenue to $395.1 million and adjusted earnings per diluted share of $0.68 for the fourth quarter of 2019. The company issued its financial guidance for 2020.
Reported revenue increased 3.1% to $395.1 million, with organic sales increasing 4.6% over Q4 2018.
GAAP earnings per diluted share were $0.18, compared to $0.29 in Q4 2018.
Adjusted earnings per diluted share were $0.68, compared to $0.65 in Q4 2018.
The company expects full-year 2020 reported revenue in the range of $1.55 billion to $1.57 billion.
Revenue by Segment
Forward Guidance
The Company expects full-year 2020 reported revenue in the range of $1.55 billion to $1.57 billion, representing approximately 3% growth at the midpoint. The Company expects full-year 2020 organic sales growth to be approximately 5%. The Company expects full-year GAAP earnings per diluted share to be in the range of $1.40 to $1.45, and full-year adjusted earnings per diluted share to be in the range of $3.00 to $3.05.
Positive Outlook
- Full-year 2020 reported revenue expected in the range of $1.55 billion to $1.57 billion.
- Full-year 2020 organic sales growth expected to be approximately 5%.
- Full-year GAAP earnings per diluted share expected to be between $1.40 and $1.45.
- Full-year adjusted earnings per diluted share expected to be in the range of $3.00 to $3.05.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...